简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2013-10-17 15:07 ABRAXANE® Phase III Study of Patients with Metastatic Pancreatic Cancer Published in New England Journal of Medicine
2013-10-15 17:52 Colorcon and Evonik Industries launch marketing and technical support cooperation for Acryl-EZE®.
2013-10-15 17:43 Oakley Named President and COO of MPI Research
2013-10-15 16:44 Lundbeck and Otsuka Initiate Phase III Clinical Trials on Lu AE58054 as a New Add-on Treatment for Alzheimer's Disease
2013-10-15 16:33 Quintiles Wins Society for Clinical Research Sites’ 2013 Eagle Award
2013-10-15 16:11 Covidien Releases Clinical Data Supporting Treatment and New Approach to Peripheral Arterial Disease
2013-10-14 20:02 Eppendorf Announces the Release of the BioBLU® Single-Use Product Family
2013-10-14 19:00 Natera Expands PanoramaTM to Include Detection of Triploidy, Following Publication of Validation Data in Fetal Diagnosis and Therapy
2013-10-14 17:23 Covidien Launches New Capnography Monitoring Solution
2013-10-14 10:02 Otsuka Pharmaceutical Completes Acquisition of Astex Pharmaceuticals
2013-10-11 17:40 Digital Fitness Area Expands by 30 Percent at 2014 International CES
2013-10-11 15:51 Cegedim Relationship Management Releases Thought Leadership Whitepaper on Best Practices in Implementing, Deploying, and Optimizing Multichannel Strategy for Life Sciences Industry
2013-10-10 15:26 electroCore Signs $14 Million Deal with waveCore to Develop Wireless Vagus Nerve Stimulation Technology
2013-10-09 14:22 Overweight Dogs Die Younger
2013-10-09 11:50 PerkinElmer’s DairyGuard™ is the First Analyzer to Add Screening for Unknown Adulterants in Milk Powder
2013-10-08 21:19 Inventages Portfolio Company, Cognoptix, Demonstrates the Ability to Accurately Identify Alzheimer’s Disease
2013-10-08 18:05 Cisbio Bioassays and Orion Diagnostica Oy Sign an Agreement for Steroid Radioimmunoassays
2013-10-08 16:25 Quintiles’ Third Quarter 2013 Earnings Call Scheduled for Thursday, October 31st
2013-10-08 15:25 KCI, LifeCell and Systagenix to Form One Company Focused on Transformational Healing Solutions under the Leadership of President & CEO Joe Woody
2013-10-08 14:50 TranScrip Partners Announce Hong Kong Expansion